BrightKaire Featured on i24NEWS: Transforming Depression Treatment with Precision Psychiatry
In a new segment on i24NEWS, NeuroKaire’s groundbreaking blood test, BrightKaire, is spotlighted for its ability to match patients with the right antidepressant in weeks—not months. This feature highlights the urgent need for personalized approaches in mental health and how BrightKaire is reshaping the future of depression care.
Every year, millions of patients with depression endure long, uncertain journeys through trial-and-error treatment. In this i24NEWS feature, NeuroKaire brings visibility to the human cost of that delay and offers a solution.
The story dives into BrightKaire, our first-of-its-kind blood test that leverages patient-derived neurons and AI to guide antidepressant selection based on biology, not guesswork. By offering a faster, data-driven pathway to effective treatment, BrightKaire empowers clinicians and patients with the clarity they’ve long needed.
This feature is a powerful reflection of what’s possible when innovation in neuroscience meets deep empathy for the patient experience.
Contact Us
78 John Miller Way,
Kearny, NJ 07032, USA
Yigal Alon Street 126
Tel Aviv-Yafo, Israel